Treatment strategies and prognostic factors of 2018 FIGO stage IIIC cervical cancer: a review

F Qin, H Pang, T Yu, Y Luo… - Technology in cancer …, 2022 - journals.sagepub.com
Cervical cancer is the fourth most common malignant tumor globally in terms of morbidity
and mortality. The presence of lymph node metastasis (LNM) is an independent prognostic …

Radiotherapy of cervical cancer

C Chargari, K Peignaux, A Escande, S Renard… - Cancer …, 2022 - Elsevier
External beam radiotherapy and brachytherapy are major treatments in the management of
cervical cancer. For early-stage tumours with local risk factors, brachytherapy is a …

Management of nodal disease in advanced cervical cancer

IM Jürgenliemk-Schulz, S Beriwal… - Seminars in Radiation …, 2019 - Elsevier
During the last decade the adoption of image-guided adaptive brachytherapy has
dramatically improved local control in patients with locally advanced cervical cancer (LACC) …

ESGO/ESTRO quality indicators for radiation therapy of cervical cancer

C Chargari, K Tanderup, F Planchamp, L Chiva… - Radiotherapy and …, 2023 - Elsevier
Abstract Background The European Society of Gynaecological Oncology (ESGO) has
previously defined and established a list of quality indicators for the surgical treatment of …

Treatment of bulky lymph nodes in locally advanced cervical cancer: boosting versus debulking

EP Olthof, H Wenzel, J van der Velden… - International Journal of …, 2022 - ijgc.bmj.com
Objective Treatment strategies for bulky lymph nodes in patients with locally advanced
cervical cancer scheduled for definitive chemoradiation include nodal boosting with …

[HTML][HTML] Nodal failure after chemo-radiation and MRI guided brachytherapy in cervical cancer: Patterns of failure in the EMBRACE study cohort

CN Nomden, R Pötter, AAC de Leeuw… - Radiotherapy and …, 2019 - Elsevier
Abstract Purpose/Objective (s) To investigate the patterns of nodal failure in patients
enrolled in the international multicentre EMBRACE study. Materials/Methods Nodal disease …

Correlation between pelvic bone marrow radiation dose and acute hematological toxicity in cervical cancer patients treated with concurrent chemoradiation

T Kumar, A Schernberg, F Busato… - Cancer management …, 2019 - Taylor & Francis
Purpose To evaluate the association between pelvic bone marrow (BM) dose volume
parameters and probability of acute hematological toxicity (HT), a cohort of cervical cancer …

[HTML][HTML] Efficacy of lymph node dissection on stage IIICr of cervical cancer before CCRT: study protocol for a phase III, randomized controlled clinical trial …

M He, M Guo, Q Zhou, Y Tang, L Zhong… - Journal of …, 2023 - ncbi.nlm.nih.gov
Background Cervical cancer is still present a major public health problem, especially in
developing countries. In International Federation of Gynaecology and Obstetrics 2018 …

[HTML][HTML] Prognostic factors of dose-response relationship for nodal control in metastatic lymph nodes of cervical cancer patients undergoing definitive radiotherapy …

WH Lee, GE Kim, YB Kim - Journal of Gynecologic Oncology, 2022 - ncbi.nlm.nih.gov
Objective Regional control is occasionally unsatisfactory in cervical cancer, with the optimal
radiation dose for nodal metastases in definitive radiotherapy (RT) with concurrent …

[HTML][HTML] Image-guided intensity-modulated radiotherapy in patients with FIGO IIIC1 cervical cancer: efficacy, toxicity and prognosis

Q Meng, X Liu, K Hu, X Hou, F Zhang, W Wang… - Journal of …, 2023 - ncbi.nlm.nih.gov
Background: To investigate the efficacy, toxicity and prognosis of image-guided intensity-
modulated radiotherapy (IG-IMRT) in patients with FIGO IIIC1 cervical cancer. Methods: We …